Deputy Director, Mycology Reference Centre, University Hospital of South Manchester NHS Foundation Trust
Verified email at - Homepage
Cited by
Cited by
EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility …
JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical Microbiology and Infection 14 (4), 398-405, 2008
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus
JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ...
Emerging infectious diseases 21 (6), 1041, 2015
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
A Bueid, SJ Howard, CB Moore, MD Richardson, E Harrison, P Bowyer, ...
Journal of Antimicrobial Chemotherapy 65 (10), 2116-2118, 2010
High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease
DW Denning, S Park, C Lass-Florl, MG Fraczek, M Kirwan, R Gore, ...
Clinical infectious diseases 52 (9), 1123-1129, 2011
The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus
MG Fraczek, M Bromley, A Buied, CB Moore, R Rajendran, R Rautemaa, ...
Journal of Antimicrobial Chemotherapy 68 (7), 1486-1496, 2013
Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts
JL Rodriguez-Tudela, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical microbiology and infection 9 (8), i-viii, 2003
Multi-azole resistance in Aspergillus fumigatus
SJ Howard, I Webster, CB Moore, RE Gardiner, S Park, DS Perlin, ...
International journal of antimicrobial agents 28 (5), 450-453, 2006
Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, MC Arendrup, MA Pfaller, LX Bonfietti, B Bustamante, ...
Antimicrobial agents and chemotherapy 57 (12), 5836-5842, 2013
Adverse reactions to voriconazole
AE Boyd, S Modi, SJ Howard, CB Moore, BG Keevil, DW Denning
Clinical infectious diseases 39 (8), 1241-1244, 2004
Pregnancy-related changes in the maternal gut microbiota are dependent upon the mother's periconceptional diet
W Gohir, FJ Whelan, MG Surette, C Moore, JD Schertzer, DM Sloboda
Gut microbes 6 (5), 310-320, 2015
Antifungal drug resistance in Aspergillus
CB Moore, N Sayers, J Mosquera, J Slaven, DW Denning
Journal of Infection 41 (3), 203-220, 2000
High prevalence of antifungal resistance in Candida spp. from patients with AIDS
D Law, CB Moore, HM Wardle, LA Ganguli, MGL Keaney, DW Denning
Journal of Antimicrobial Chemotherapy 34 (5), 659-668, 1994
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing …
M Cuenca-Estrella, CB Moore, F Barchiesi, J Bille, E Chryssanthou, ...
Clinical microbiology and infection 9 (6), 467-474, 2003
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis
TW Felton, C Baxter, CB Moore, SA Roberts, WW Hope, DW Denning
Clinical infectious diseases 51 (12), 1383-1391, 2010
Toxicodynamics of itraconazole: implications for therapeutic drug monitoring
JM Lestner, SA Roberts, CB Moore, SJ Howard, DW Denning, WW Hope
Clinical infectious diseases 49 (6), 928-930, 2009
In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp
KL Oakley, CB Moore, DW Denning
Antimicrobial agents and chemotherapy 41 (5), 1124-1126, 1997
A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species
F Bongomin, RO Oladele, S Gago, CB Moore, MD Richardson
Mycoses 61 (5), 290-297, 2018
Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection
EM Johnson, KL Oakley, SA Radford, CB Moore, P Warn, DW Warnock, ...
Journal of Antimicrobial Chemotherapy 45 (1), 85-93, 2000
In Vitro Activity of the Echinocandin Antifungal Agent LY303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp
KL Oakley, CB Moore, DW Denning
Antimicrobial agents and chemotherapy 42 (10), 2726-2730, 1998
Be healthy in pregnancy: exploring factors that impact pregnant women's nutrition and exercise behaviours
LN Grenier, SA Atkinson, MF Mottola, O Wahoush, L Thabane, F Xie, ...
Maternal & child nutrition 17 (1), e13068, 2021
The system can't perform the operation now. Try again later.
Articles 1–20